Fidelity SPDR Advertisement
Home > Boards > Free Zone > Health and Sciences > Biotech Values

Normally I'd agree - but on 3yr paper

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
10nisman Member Profile
 
Followed By 6
Posts 1,506
Boards Moderated 0
Alias Born 10/26/03
160x600 placeholder
IBM posted sharply lower earnings in its third quarter as sales fell across most of its segments and it unveiled a deal to transfer its semiconductor operations to Globalfoundries. IBM shares down 7% premarket.
More Top Equities Stories Of The Day
U.S. Stocks Mixed as IBM Drags Dow Down
FTSE 100 Loses Ground In Topsy-turvy Trade; Shire Losses Deepen
Stifel Financial to Hire Two Former Merrill Lynch Advisers
U.S. Stocks Gain, but IBM Weighs on Dow
U.S. Stocks Rebound After Recent Losses
U.S. Hot Stocks: Hot Stocks to Watch
India's Snapdeal in Talks With SoftBank, Others
Halliburton Guidance Expected to Shed Light On Oil Price Worries -- Earnings Preview
10nisman   Thursday, 09/23/10 12:08:13 PM
Re: wallstarb post# 104887
Post # of 183008 
Quote:
Normally I'd agree - but on 3yr paper it doesnt have the duration for a longer term investment, and unless MSFT is buying junk bonds with it I really dont see the point for them. Perhaps an acquisition on the horizon - or maybe they are buying some CMOs

The vast majority of MSFT's cash is overseas and thus to get around paying taxes to repatriate it they chose to issue debt at insanely attractive levels. MSFT will likely use the cash to pay its dividend and buy-back shares.

10nis

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist